Walker on Progress

A breakthrough review validates harnessing neutrophils, the immune system's foot soldiers, for cancer, with a new therapy now heading to human trials.

An award-winning James Hardie partner expands to Wisconsin, promising to raise the standard for home exteriors with climate-tested, design-forward solutions.

A novel drug derived from ibogaine, DMX-1001 aims to repair brain circuits damaged by alcohol. The FDA has now cleared it for Phase 2 human trials.

Hundreds of lupus advocates descended on Washington, demanding policy reform and research funding, and their persistent efforts are already yielding major results.

A landmark acquisition creates Canada's largest employee ownership advisor just as a critical tax incentive for business transitions faces a looming deadline.

A new report reveals cybercriminals are bypassing firewalls by exploiting human behavior, with vendor email scams and social engineering on the rise.

A record-breaking medical conference reveals a major shift in medicine, as practitioners move from simply managing aging to pursuing biological age reversal.

S&P Global Energy and the UN SSE are launching a major partnership to equip global stock exchanges with the data needed to unlock trillions in green finance.

Sion Power's new 500 Wh/kg lithium-metal cells promise to revolutionize drone warfare, dramatically extending flight times and boosting US supply chain security.

A new partnership is bringing science-backed functional mushrooms to pet food, tapping into a booming market for advanced pet wellness. Here's why.

A new AI-driven platform moves beyond static reports, offering continuous genomic updates to give cancer patients access to the latest treatment options.

Questor Technology announces a major leadership change as its long-serving CEO exits. Interim leaders now face steering the clean tech firm amid growth.

With 26 new MLS partnerships, Restb.ai's embedded AI is now used by over a million agents, automating tasks and transforming property data behind the scenes.

A new report reveals 87% of ad pros see their industry's model as broken. AI, tech sprawl, and client pressure are forcing a painful transformation.

A national advocacy group accuses New Mexico's AG of using 'Trump-style' fear tactics in a child welfare report, warning his approach could harm more children.

With Cigna's backing, Accord's IMULDOSA is set to challenge a blockbuster drug, promising significant savings for patients and the healthcare system.

As Surgery Partners sets its Q1 2026 earnings call, investors are watching closely to see if it can overcome recent headwinds and capitalize on industry trends.

For the fourth straight year, Golden State Wealth Management is a top US advisory firm. We explore the advisor-centric model driving its consistent success.

Varvara Development Group raises C$15M to fund its cyanide-free gold mine in Romania, as major shareholder Eldorado Gold increases its stake to 19.9%.

While national reading scores falter, a Mississippi school sees 63% of its most challenged readers make gains. Here's how they are doing it.